Singapore markets closed

Aadi Bioscience, Inc. (AADI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.9900-0.2700 (-5.13%)
At close: 04:00PM EST
4.9600 -0.03 (-0.60%)
After hours: 07:30PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 122.38M
Enterprise value 4.42M
Trailing P/E 1.89
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)5.77
Price/book (mrq)1.04
Enterprise value/revenue 0.19
Enterprise value/EBITDA -0.07

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 3-60.72%
S&P500 52-week change 314.23%
52-week high 313.6000
52-week low 33.8800
50-day moving average 34.5720
200-day moving average 36.6425

Share statistics

Avg vol (3-month) 3111.12k
Avg vol (10-day) 3112.95k
Shares outstanding 524.53M
Implied shares outstanding 624.53M
Float 816.39M
% held by insiders 112.51%
% held by institutions 160.70%
Shares short (14 Nov 2023) 4743.74k
Short ratio (14 Nov 2023) 48.15
Short % of float (14 Nov 2023) 44.61%
Short % of shares outstanding (14 Nov 2023) 43.03%
Shares short (prior month 12 Oct 2023) 4801.28k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 326 Aug 2021

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin -272.67%
Operating margin (ttm)-299.53%

Management effectiveness

Return on assets (ttm)-26.10%
Return on equity (ttm)-44.14%

Income statement

Revenue (ttm)23.25M
Revenue per share (ttm)0.87
Quarterly revenue growth (yoy)40.40%
Gross profit (ttm)-18.78M
EBITDA -69.52M
Net income avi to common (ttm)-63.41M
Diluted EPS (ttm)-2.3200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)119.33M
Total cash per share (mrq)4.87
Total debt (mrq)1.37M
Total debt/equity (mrq)1.16%
Current ratio (mrq)6.48
Book value per share (mrq)4.82

Cash flow statement

Operating cash flow (ttm)-61.33M
Levered free cash flow (ttm)-39.17M